Advancements in technology will continue to propel efficiencies in clinical trials in 2016 and beyond. That is the main takeaway from four experts I interviewed who shared their insights on trends expected in the clinical arena. Companies are continuing to turn to risk-based monitoring (RBM) to identify risk and leverage source data verification (SDV) where and when appropriate. Sponsors and CROs are increasingly turning to electronic health records (EHRs) and electronic medical records (EMRs) to identify potential patients for inclusion in clinical trials. It also seems 2016 and 2017 may well be the years that more companies finally begin to routinely incorporate mobile technologies into their trials. Any way you look at it, technology is quickly moving front and center in the effort to simplify, shorten, and bring down the cost of clinical trials.